Patents Assigned to KOSA BIO INC.
  • Publication number: 20250064875
    Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating muscle diseases. Particularly, an elderberry extract or a monosaccharide- and amino acid-coupled compound, according to the present disclosure exhibits the effects of inhibiting muscle cell apoptosis, inhibiting the expression of inflammatory cytokines, promoting the secretion of testosterone, inhibiting the expression of muscle atrophy markers and myostatin and causing muscle to recover in sarcopenia animal models, and thus can be effectively used in the treatment of muscle diseases.
    Type: Application
    Filed: November 10, 2022
    Publication date: February 27, 2025
    Applicant: KOSA BIO INC.
    Inventors: Hyunseok KONG, Jiyeon KIM, Seonhwa HONG, Jongsu KIM
  • Publication number: 20240245742
    Abstract: The present invention relates to a composition comprising an elderberry extract as an effective component for preventing, treating, or alleviating andropause syndrome, wherein the elderberry extract of the present invention increases testosterone secretion in sperm cells and andropause syndrome animal models, and thus can be usefully employed as a pharmaceutical or food composition for preventing, treating or alleviating andropause syndrome.
    Type: Application
    Filed: February 29, 2024
    Publication date: July 25, 2024
    Applicant: Kosa Bio Inc.
    Inventor: Hyun Seok KONG
  • Publication number: 20220000954
    Abstract: The present invention relates to a composition comprising an elderberry extract as an effective component for preventing, treating, or alleviating andropause syndrome, wherein the elderberry extract of the present invention increases testosterone secretion in sperm cells and andropause syndrome animal models, and thus can be usefully employed as a pharmaceutical or food composition for preventing, treating or alleviating andropause syndrome.
    Type: Application
    Filed: October 15, 2019
    Publication date: January 6, 2022
    Applicant: KOSA BIO INC.
    Inventor: Hyun Seok KONG